Cancer Data Science Pulse

High-Performance Computing (HPC)

Watch our time capsule video to learn about the current status of the field and new technologies that are sure to be important as we embark on the next era of cancer data research.

What do winter storms, airplanes, and cancer research have in common? In this blog, experts on meteorology, aerospace engineering, and radiation oncology explore what we can learn from these very different fields to further advance how we target and apply radiation to more effectively treat cancerous tumors.

This blog post, the fifth, concludes our series that discusses the principles underlying the collaborative project "Joint Design of Advanced Computing Solutions for Cancer (JDACS4C)."

NCI continues to identify and link external data sources with SEER data to enable the expansion of longitudinal data to form patient trajectories and to support modeling efforts. To inform the incorporation of those additional sources, NCI compiled an extensive breast cancer recurrence data dictionary to identify recurrence-related data elements across multiple sources, including pathology, radiology, pharmacy, biomarkers, procedures, comorbidities, patient-generated information, and radiation oncology.

This is the third in a series of posts that discuss the principles underlying the three-year collaborative program "Joint Design of Advanced Computing Solutions for Cancer (JDACS4C)."

This is the second of a series of posts that discuss the principles underlying the NCI-DOE Collaborations.

This is the first of a series of posts that discuss the pilot collaborative program “Joint Design of Advanced Computing Solutions for Cancer (JDACS4C)” being pursued by the National Cancer Institute (NCI) and the Department of Energy (DOE).

In recent years, genomics has been described as a big data science on par with the likes of Twitter, YouTube, and the scientific pursuit of understanding the universe.

The recent weeks have been momentous as the high-performance computing (HPC) community embraced the challenge of precision medicine.